article thumbnail

Genetic Testing Company 23andMe Files for Bankruptcy

The HIPAA Journal

The direct-to-consumer genetic testing company 23andMe has announced it has entered Chapter 11 bankruptcy and has asked the US Bankruptcy Court for the Eastern District of Missouri to facilitate a sale to maximize the value of its business. 23andMe provides saliva-based DNA test kits to help customers identify and track their ancestry.

Tests 83
article thumbnail

Most Baby Foods Sold In US Don’t Meet International Nutritional Standards And Contain ‘Misleading’ Messaging, Study Suggests

Forbes Healthcare

Although fruit pouches were the fastest-growing products—with sales jumping 900% between 2010 and 2023—the researchers found they were the most unhealthy food items tested.

Tests 363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is the FDA too lax: Part 2

Sensible Medicine

Fruquintinib In 2023, the FDA approved this drug in a placebo controlled trial in colon cancer. Had Fruquintinib been tested against the actual standard of care, I doubt it would have won. Wait, is placebo really the appropriate control arm for pancreas cancer? That doesn’t sound right. I discuss this trial at minute 39 here.

Tests 325
article thumbnail

Hundreds of Patients Wrongly Diagnosed with Cancer Due to Software Mix-up

Scrubs

The biotech firm known as Grail made headlines earlier this year thanks to its signature Galleri blood tests, which can detect up to 50 different kinds of cancer early on to improve patient outcomes. The tests were hailed as the “first of its kind” when it hit the market in 2023. It’s that they simply didn’t exist.

Tests 188
article thumbnail

Optum: Testing Time for an Invisible Empire

The Healthcare Blog

Then someone discovered that the largest living thing in the world was actually the 106 acre, 47 thousand tree Pando aspen grove in central Utah, which genetic testing revealed to be a single organism. Source: 2023 UNH 10K For most of the past decade, Optum has been driving force of incremental profit growth for United.

Tests 132
article thumbnail

Artificial Intelligence can be the Catalyst for Transformative Change at NIH

Sensible Medicine

Researchers have in rare cases demonstrated the potential of this proactive approach, such as I have done tracking demand for HIV testing , increased suicidal ideation , or recently rising concerns about gambling addictions , but do so relying on limited data and still detect these important events after significant delays.

article thumbnail

Physicians’ Confidence In and Use of AI is Rising, AMA Finds – Coupling Demand With Many Enabling Factors

Health Populi

This study updates AMA’s survey conducted in 2023 and found significantly growing confidence and utilization of AI for certain use cases. The AMA polled U.S. As we say in patient engagement and advocacy mantras, “Nnthing about me, without me.” ” Here, the physicians are expressing their voice.